METHADONE TREATMENT QUALITY ASSURANCE SYSTEM FEASIBILITY STUDY

ICR 199107-0930-002

OMB: 0930-0154

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
ICR Details
0930-0154 199107-0930-002
Historical Active
HHS/SAMHSA
METHADONE TREATMENT QUALITY ASSURANCE SYSTEM FEASIBILITY STUDY
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 10/31/1991
Retrieve Notice of Action (NOA) 07/24/1991
Phase I of this feasibility study is approved for use through 10/92 under the following conditions: 1) Prior to fielding the instrument, NIDA:(a) justifies the practical utility of interviewer problem severity rating questions (e.g. questio D8) and explains how inter rater reliability will be ensured for such questions; and (b) justifies the validity of responses to questions su as J6a. and J18a. which ask clients whether physical or emotional problems were due to drug use. In the absence of adequate justification from the Department, OMB may ask that such questions be deleted from the instrument prior to use. 2) No later than 12/91, NIDA provides OMB with a comprehensive explanation of its plans to evaluate potential bias in non participati programs, client non respondents, and item specific non response. In addition, NIDA should present a plan for: 1) validation of client responses in all outcome categories; and 2) controlling for facility bias in administering the survey and responding to the Program Directo questionnaire. Finally, NIDA should articulate how results from NDATU or the Drug Research Study could be used to supplant or validate treatment program responses. 3) NIDA concentrates on the development of a case mix measurement and adjustment methodology in Phase I of this effort and will present this methodology in its next package for OMB clearance. (continued)
  Inventory as of this Action Requested Previously Approved
10/31/1992 10/31/1992
5,430 0 0
3,511 0 0
0 0 0

THE PROJECT EXAMINES THE FEASIBILITY OF A PERFORMANCE REPORTING SYSTEM FOR METHADONE TREATMENT PROGRAMS. RELATIVE PERFORMANCE ON OBJECTIVE, VERIFIABLE OUTCOMES WILL BE ASSESSED CONSIDERING CLIENT CASE-MIX. INFORMATION FROM PERFORMANCE REPORTS TO PROGRAMS WILL ASSIST IN IMPROVING THE QUALITY OF TREATMENT THEY PROVIDE. THIS SUBMISSION IS F THE FIELD TEST ONLY TO DEVELOP INSTRUMENT AND PROCEDURES.

None
None


No

1
IC Title Form No. Form Name
METHADONE TREATMENT QUALITY ASSURANCE SYSTEM FEASIBILITY STUDY

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 5,430 0 0 5,430 0 0
Annual Time Burden (Hours) 3,511 0 0 3,511 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/24/1991


© 2024 OMB.report | Privacy Policy